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Abstract
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but
serious dermatologic diseases with many potential multisystem complications. We
describe the case of an 8-year-old girl who developed severe SJS/TEN overlap syn-
drome (25% of her body surface area was affected) complicated by pancreatitis and
bronchiolitis obliterans. These rare complications emphasize the need for careful,
intensive monitoring of possible complications and an interdisciplinary team
approach to provide optimal treatment and follow-up.
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1 | INTRODUCTION
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis
(TEN) are rare but serious dermatologic diseases characterized by
sudden onset of high fever, signs of systemic toxicity, and a variable
degree of mucocutaneous exfoliation.1 In addition to cutaneous
involvement, multisystem manifestations may occur and be responsi-
ble for much of the morbidity and mortality associated with these
conditions.1,2 The conjunctiva, trachea, buccal mucosa, gastrointesti-
nal tract, and genitourinary tract are often involved. A severe and
often progressive form of bronchiolitis obliterans has become an
increasingly recognized complication. Pancreatic involvement has
been reported in a few adult case reports.3–5 The pathophysiology
has not been determined and undisputed radiologic evidence of pan-
creatitis in the course of SJS or TEN is lacking.3
Clinical and radiologic evidence of pancreatitis and bronchiolitis
obliterans complicating a course of a severe multisystem SJS/TEN
overlap in an 8-year-old child are the basis of this report.
2 | CASE REPORT
An 8-year-old girl presented to the emergency department with
high-grade fever, bilateral conjunctivitis, and rash for 2 days. The
parents reported having given the child paracetamol and nimesulide,
a cyclooxygenase 2 selective inhibitor antiinflammatory agent, 4 days
before for nasal drip and throat pain. The girl was born in India, had
been in Portugal for the previous 2 years, and was being treated
with iron for iron deficiency anemia for the previous 6 months. Her
past medical history was unremarkable. Family history was notable
for human immunodeficiency virus type1 infection in her parents
and sister.
Physical examination revealed a vesicular erythematous eruption
on her back, face, and arms covering approximately 10% of her body
surface area (BSA). Erosions on her lips and buccal mucosa, eyelid
edema, and severe bilateral exudative conjunctivitis were also noted.
Initial laboratory results demonstrated lymphopenia (leukocytes
6,730/lL, lymphocytes 540/lL) and high hepatic enzymes (aspartate
aminotransferase [AST] 118 U/L, normal range <35 U/L; alanine
aminotransferase [ALT] 53 U/L, normal range <39 U/L; gamma-glu-
tamyl transferase [GGT] 56 U/L, normal range <22 U/L; alkaline
phosphatase [ALP] 265 U/L, normal range 51-332 U/L) and C-reac-
tive protein (135 mg/L, normal range <5 mg/L). Serology and molec-
ular testing at admission and 3 weeks later were negative for viral
hepatitis A, B, C, and E; Epstein–Barr virus; cytomegalovirus; herpes
simplex virus; varicella-zoster virus; enterovirus; adenovirus; and
Mycobacterium and Mycoplasma pneumonia. Stevens–Johnson syn-
drome was diagnosed and the child was transferred to an isolation
room. All drugs administered before the development of clinical signs
were discontinued. She was started on intravenous hydration,
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application of normal saline dressings on denuded areas, and a
greasy emollient (mixture of soft and liquid paraffin) on the remain-
ing skin and chloramphenicol for the ocular involvement.
Over the first 8 days of hospitalization there was progression of
the cutaneous lesions, affecting a total of 25% of her BSA (Figure 1)
with epidermal detachment of approximately 15% of her BSA, with-
out evidence of cutaneous infection, and progressive resolution with
supportive care over the next month. The mucosal lesions resolved
over the 6 weeks after admission.
Ophthalmologic evaluation on day 2 revealed bilateral keratocon-
junctivitis with deepithelization. Over the following weeks, bilateral
corneal ulcers and symblepharon appeared and were treated using
mechanical debridement and topical chloramphenicol. Three weeks
after admission she developed excruciating lumbar pain accompanied
by diffuse abdominal pain, especially in the epigastric area. Blood
tests revealed markedly high serum amylase (600 U/L, normal range
0-31 U/L) and lipase (731 U/L, normal range 0-350 U/L) levels,
mixed hyperbilirubinemia (total 1.3 mg/dL, normal range 0.3-1.2 mg/
dL; direct 1.14 mg/dL, normal range 0-0.2), and high hepatic enzyme
levels (AST 225 U/L, ALT 232 U/L, GGT 950 U/L, ALP 803 U/L).
Abdominal sonography revealed a heterogeneous echostructure of
the pancreas with preserved dimensions and evidence of biliary
sludge without biliary tract dilation. Magnetic resonance cholan-
giopancreatography revealed edema of the medial third of the pan-
creatic body and dilation of the medial third of the Wirsung duct
surrounded by two areas of stenosis, one in the proximal extremity
and another in the area of transition to the pancreatic tail, concor-
dant with a multifocal intrinsic stenosis process (Figure 2). A diagno-
sis of acute pancreatitis was made. Oral intake was stopped and
intravenous fluids, analgesia, and ursodeoxycholic acid were initiated.
Clinical complaints of pain subsided and a progressive normalization
of pancreatic enzymes was noted over the next 2 weeks. Oral intake
was reintroduced without untoward effects.
She was febrile for a total of 36 days despite multiple antibiotics
cycles. On day 34 she was treated with intravenous immunoglobulin
1 g/kg/d for 3 days, with subsequent remission of fever.
During the fifth week of hospitalization she developed progres-
sive dyspnea and wheezing, with poor response to bronchodilators,
and cervical anterior region localized pain and palpable subcutaneous
emphysema. Computed tomography did not show parenchyma
involvement but revealed a moderate pneumomediastinum with cer-
vical extension. She was started on broad-spectrum antibiotics, corti-
costeroids, and supplemental oxygen. Over the next 2 weeks there
was persistent wheezing and the need for oxygen supplementation.
Pulmonary function tests revealed severe obstructive pattern with a
marked increase in residual value and a lack of response to bron-
chodilators. Upper endoscopy and bronchoscopy were normal. A pre-
sumptive diagnosis of bronchiolitis obliterans was made and she was
maintained on corticosteroid therapy for 7 days (2 mg/kg/d) with
subsequent slow tapering. On discharge, she was kept on a mainte-
nance dose of 16 mg/d (0.7 mg/kg/d). Pulmonary biopsy 6 months
after hospital discharge revealed peribronchiolar fibrosis with marked
inflammatory changes of the pulmonary parenchyma. She was dis-
charged 3 months after admission with complete resolution of pan-
creatitis, marked decrease in visual acuity, extensive areas of
cutaneous hyperpigmentation, dependence on nocturnal oxygen sup-
plementation, and maintenance corticosteroid therapy.
3 | DISCUSSION
SJS and TEN are rare but serious conditions with high morbidity and
mortality often triggered by a drug or infection.1,5 Pathologically
they resemble second-degree burns, with widespread keratinocyte
F IGURE 1 Cutaneous and mucosal lesions on the fourth day of
disease
F IGURE 2 Multifocal stenosis of the Wirsung duct on
cholangiopancreatic magnetic resonance imaging
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necrosis in all epidermal layers.5 In addition to cutaneous involve-
ment, mucosal lesions are frequently reported, causing significant
long-term morbidity.1 Dysfunction of various organ systems, includ-
ing renal, respiratory, and digestive, may also occur.1,3
Pancreatitis occurring in individuals with SJS and TEN is well
known but is not a common finding.3,4,6 A study by Dilewski and col-
leagues6 demonstrated that 40% of individuals with SJS/TEN devel-
oped asymptomatic elevations of amylase and lipase levels. Coetzer
et al.3 reported a 25-year-old man with TEN who, like our patient,
developed clinical evidence of pancreatitis, with high serum amylase
levels and pancreatic swelling and biliary sludge without biliary tract
dilatation on ultrasonography. Our patient also had Wirsung duct
stenosis, as evidenced by magnetic resonance cholangiopancreatogra-
phy. The mechanisms of pancreatitis in these conditions are unclear.3
An immunologic pathway of pancreatic damage or hypovolemia is
thought to be the most plausible mechanism.3 Although treatment of
pancreatitis is typically fluid restriction and supportive care, the myr-
iad and timing of complications in our patient prompted us to initiate
corticosteroid and immunoglobulin therapy.
Individuals with SJS and TEN have high caloric and protein
requirements, and appropriate nutrition is necessary to increase sur-
vival.6 Children are even more vulnerable to suboptimal nutrition
because they have low lean body mass reserves.7 The diagnosis of
pancreatitis impeded the initiation of enteral nutrition, which might
have worsened the prognosis in our patient.8
Bronchiolitis obliterans has also been reported in SJS/TEN. It is
characterized by partial or complete obstruction of the bronchioles
or alveolar ducts by granulation tissue or fibrosis.9 The onset of
bronchiolitis obliterans has been reported to occur 5 days to
10 months after the development of SJS.10 Our patient presented
with dyspnea 1 month after the onset of skin lesions. Although the
pulmonary biopsy findings were nonspecific, the peribronchial fibro-
sis and the severe obstructive pattern, with no response to bron-
chodilators, were consistent with the diagnosis of bronchiolitis
obliterans. There is no consensus as to the optimal treatment for
bronchiolitis obliterans.11 Although systemic corticosteroids are fre-
quently used, their use is controversial, and large-scale studies are
lacking regarding optimal treatment and prognosis in bronchiolitis
obliterans associated with SJS/TEN.11
Management of SJS/TEN requires careful, intensive monitoring
of possible multisystem complications and an interdisciplinary team
approach to provide optimal care and follow-up.1
Given the rarity of these conditions, large, multicenter,
prospective studies are required to establish best practices for
management and to improve outcomes with these life-threatening
diseases.
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